Form 4: Insmed Inc. Chief Legal Officer Michael Smith Reports Stock Transactions

Chief Legal Officer Michael Smith reports acquisition of shares through vesting of Performance Stock Units and subsequent sale to cover tax obligations.

Summary

• Michael Smith, Chief Legal Officer of Insmed Inc., reported transactions involving the company's common stock.
• On February 5, 2025, Smith acquired 47,295 shares of common stock upon the vesting of Performance Stock Units (PSUs) granted on January 6, 2022.
• These PSUs vested due to the achievement of applicable performance and service conditions.
• On February 6, 2025, Smith sold 20,650 shares to satisfy tax withholding obligations related to the vesting of the PSUs and to cover broker fees.
• The shares were sold at a weighted average price of $80.9, with individual prices ranging from $80.57 to $81.43 per share.
• Following these transactions, Smith beneficially owns 96,610 shares of Insmed Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The vesting of PSUs is a positive sign, but the sale of shares is a common practice to cover tax obligations.

Positives

• The vesting of Performance Stock Units indicates that performance and service conditions were met, which could be viewed positively.

Negatives

• The sale of shares to cover tax obligations and broker fees could be interpreted as a need for liquidity, although it is a common practice.

Risks

• The document does not explicitly mention any risks.

Industry Context

Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This filing is specific to Insmed Inc. and doesn't provide broader industry context.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in beneficial ownership, but the overall impact is likely minimal.

Key Dates